These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27249935)

  • 21. Update on antibacterial and antifungal drugs - can we master the resistance crisis?
    Theuretzbacher U; Mouton JW
    Curr Opin Pharmacol; 2011 Oct; 11(5):429-32. PubMed ID: 21903474
    [No Abstract]   [Full Text] [Related]  

  • 22. The microbiology of secondary and postoperative pancreatic infections: implications for antimicrobial management.
    Behrman SW; Bahr MH; Dickson PV; Zarzaur BL
    Arch Surg; 2011 May; 146(5):613-9. PubMed ID: 21576614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Septicemia with gram-negative bacilli. The possibilities and limits of an etiological therapy].
    Grigore L
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(3-4):151-60. PubMed ID: 9116405
    [No Abstract]   [Full Text] [Related]  

  • 24. The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms.
    Hagihara M; Crandon JL; Nicolau DP
    Expert Opin Drug Saf; 2012 Mar; 11(2):221-33. PubMed ID: 22074343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare nonfatal presentation of disseminated Chromobacterium violaceum sepsis.
    Saboo AR; Vijaykumar R; Save SU; Bavdekar SB
    J Microbiol Immunol Infect; 2015 Oct; 48(5):574-7. PubMed ID: 23380618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic infections.
    Golkar FC; Rosemurgy AS
    Arch Surg; 2011 May; 146(5):619. PubMed ID: 21739658
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibiotic therapy by suppurative diseases of the abdominal cavity and soft tissues].
    Sazhin VP; Bodrova NG; Klimov DE; Iurishchev VA; Avdovenko AL; Sazhin IV
    Khirurgiia (Mosk); 2010; (6):4-9. PubMed ID: 20559216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of teicoplanin's therapeutic efficacy in immunocompromised patients with staphylococcal sepsis.
    Orani A; Fossati M; Castelli N; Sala A
    J Chemother; 1989 Jul; 1(4 Suppl):716-9. PubMed ID: 16312605
    [No Abstract]   [Full Text] [Related]  

  • 30. Returning to the pre-antibiotic era in the critically ill: the XDR problem.
    Paterson DL; Lipman J
    Crit Care Med; 2007 Jul; 35(7):1789-91. PubMed ID: 17581370
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents.
    van den Hoogen A; Gerards LJ; Verboon-Maciolek MA; Fleer A; Krediet TG
    Neonatology; 2010; 97(1):22-8. PubMed ID: 19571584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New trends in pharmacogenomic strategies against resistance development in microbial infections.
    Ohlsen K; Dandekar G; Schwarz R; Dandekar T
    Pharmacogenomics; 2008 Nov; 9(11):1711-23. PubMed ID: 19018725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic resistance in cancer patients.
    Gudiol C; Carratalà J
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):1003-16. PubMed ID: 24834465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current treatment of endocarditis : Innovations and controversies].
    Hitzenbichler F; Olic J; Hanses F; Salzberger B; Fischer M; Baessler A
    Internist (Berl); 2019 Oct; 60(10):1111-1117. PubMed ID: 31444523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of microorganisms of the wound in postop complications].
    Kholodna LS; Holeva OH; Liubchenko TA; Korzhyk NP; Holev GV
    Klin Khir; 1999; (8):25-7. PubMed ID: 10584492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal sepsis in hospital-born babies.
    Butt T; Ahmad RN; Usman M
    J Coll Physicians Surg Pak; 2004 Feb; 14(2):125; author reply 125-6. PubMed ID: 15228882
    [No Abstract]   [Full Text] [Related]  

  • 37. Neutropenic infections: strategies for empirical therapy.
    Kibbler CC
    J Antimicrob Chemother; 1995 Oct; 36 Suppl B():107-17. PubMed ID: 8601537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of antibiotic resistance and resistance mechanisms. Foreword.
    Bonomo RA; Rossolini GM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):549-50. PubMed ID: 18847392
    [No Abstract]   [Full Text] [Related]  

  • 39. Emergence of multidrug resistance in bacteria and impact on antibiotic expenditure at a major army medical center caring for soldiers wounded in Iraq and Afghanistan.
    Zapor MJ; Erwin D; Erowele G; Wortmann G
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):661-3. PubMed ID: 18593337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Severe sepsis as a complication of descending necrotizing mediastinitis due to a peritonsillar abscess. A case study].
    Machała W; Smiechowicz K; Gaszyński T
    Otolaryngol Pol; 2006; 60(2):211-5. PubMed ID: 16903340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.